SDI Limited Advances Acquisition with Regulatory and Financing Conditions Met

Regulatory and Financing Milestones Achieved

SDI Limited (ASX:SDI) has announced that critical conditions precedent for its proposed scheme of arrangement acquisition by InnoXvest Dental, a subsidiary of Beijing Guoci Kebo Technology and ultimately controlled by Shandong Sinocera Functional Material, have been satisfied. This includes obtaining key Chinese regulatory approvals from the National Development and Reform Commission (NDRC), Ministry of Commerce (MOFCOM), and State Administration of Foreign Exchange (SAFE), clearing a significant hurdle in the cross-border transaction.

In addition, SDI secured the necessary financing for its Project Montrose capital expenditures, with confirmations from financiers that releasing mortgages will not trigger prepayment or break costs. This financing assurance is crucial for SDI’s ongoing operational plans amid the acquisition process.

Shareholder and Court Approvals Remain Pending

While these milestones mark substantial progress, the scheme’s implementation still hinges on shareholder approval at a virtual meeting set for 22 June 2026 and subsequent approval by the Supreme Court of New South Wales. The SDI Board unanimously recommends shareholders vote in favour of the scheme, provided no superior proposal emerges and the Independent Expert continues to endorse the transaction as being in shareholders’ best interests.

Notably, SDI’s largest shareholder, Currango Pastoral Company, controlled by Chairman Jeffery Cheetham, holds about 45.3% of issued shares and has confirmed its intention to support the scheme under the same conditions. This backing from major shareholders and directors signals strong internal confidence in the deal’s value proposition.

Deal Valuation and Strategic Positioning

The all-cash offer values SDI shares at A$1.40 each, representing a premium over recent trading levels. SDI, a specialist dental materials manufacturer headquartered in Victoria and distributing to over 100 countries, has been navigating sector challenges including regulatory pressures on amalgam products and ongoing investments in innovation and manufacturing upgrades. The acquisition by a Sinocera-controlled entity aligns SDI with a global advanced materials group, potentially enhancing its growth and development prospects.

This update follows the dispatch of the scheme booklet and court approval to convene the shareholder meeting earlier this year, confirming steady progress toward closing the transaction Scheme Booklet dispatched to shareholders. The deal remains subject to customary conditions and approvals, with no indications yet of competing bids.